Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20853810 | 1.00 | CTSL (0.31) | CTSLCTSBCTSK | |
| SCHEMBL514300 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL514418 | 0.94 | — | — | |
| SCHEMBL514087 | 0.94 | ALDH1A1 (0.32) | — | |
| SCHEMBL20853812 | 0.94 | — | — | |
| SCHEMBL513991 | 0.94 | — | — | |
| SCHEMBL14433301 | 0.89 | MGLL (0.38) | — | |
| SCHEMBL514846 | 0.88 | MGLL (0.33) | CTSLCTSBCTSK | |
| SCHEMBL19474824 | 0.82 | MGLL (0.40) | — | |
| SCHEMBL11219356 | 0.82 | MGLL (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10859916-B2 | Composition for forming fine pattern and method for forming fine pattern using the same | MERCK PATENT GMBH (DE) | 2020-12-08 | — | — | US | claimed |
| EP-4720172-A1 | SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENES AS IONOMERS AND AS MEMBRANE MATERIALS FOR ALKALINE ELECTROLYSIS OF WATER, AND FUEL CELL | Forschungszentrum Jülich GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025242796-A1 | HYDROGENATED SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENE-ANION EXCHANGE POLYMERS AS MEMBRANE MATERIALS FOR ALKALINE WATER ELECTROLYSIS AND FUEL CELLS | Forschungszentrum Jülich GmbH (DE) | 2025-11-27 | — | — | WO | disclosed |
| WO-2024245731-A1 | SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENES AS IONOMERS AND AS MEMBRANE MATERIALS FOR ALKALINE ELECTROLYSIS OF WATER, AND FUEL CELL | Forschungszentrum Jülich GmbH (DE) | 2024-12-05 | — | — | WO | disclosed |
| US-20240036469-A1 | METHOD FOR MANUFACTURING THICKENED RESIST PATTERN, THICKENING SOLUTION, AND METHOD FOR MANUFACTURING PROCESSED SUBSTRATE | MERCK ELECTRONICS LTD. (JP) | 2024-02-01 | — | — | US | disclosed |
| EP-4264376-A1 | METHOD FOR MANUFACTURING THICKENED RESIST PATTERN, THICKENING SOLUTION, AND METHOD FOR MANUFACTURING PROCESSED SUBSTRATE | Merck Patent GmbH (DE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022129015-A1 | METHOD FOR MANUFACTURING THICKENED RESIST PATTERN, THICKENING SOLUTION, AND METHOD FOR MANUFACTURING PROCESSED SUBSTRATE | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| CN-108780284-B | Composition for forming fine pattern and method for forming fine pattern using same | AZ电子材料（卢森堡）有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-10859916-B2 | Composition for forming fine pattern and method for forming fine pattern using the same | MERCK PATENT GMBH (DE) | 2020-12-08 | — | — | US | disclosed |
| EP-3430476-B1 | COMPOSITION FOR FORMING FINE PATTERN AND METHOD FOR FORMING FINE PATTERN USING THE SAME | AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) | 2020-04-01 | — | — | EP | disclosed |
| US-7112337-B2 | Liposome composition for delivery of nucleic acid | ALZA CORPORATION (US) | 2006-09-26 | — | — | US | disclosed |
| WO-2006089168-A2 | METHODS FOR MODULATING ION CHANNELS | CORNELL RESEARCH FOUNDATION, INC. (US) | 2006-08-24 | — | — | WO | disclosed |
| US-20050191344-A1 | Liposome composition for delivery of therapeutic agents | ALZA CORPORATION | 2005-09-01 | — | — | US | disclosed |
| WO-2005070466-A2 | LIPOSOME COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS | ALZA CORPORATION (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005063745-A2 | NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF | ARENA PHARMACEUTICALS, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| US-20040197390-A1 | Neutral-cationic lipid for systemic delivery of factor VIII gene | HUANG SHI-KUN (US) | 2004-10-07 | — | — | US | disclosed |
| US-20040166150-A1 | Neutral-cationic lipid for systemic delivery of Factor VIII gene | HUANG SHI-KUN (US) | 2004-08-26 | — | — | US | disclosed |
| US-20030031704-A1 | Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic | ALZA CORPORATION | 2003-02-13 | — | — | US | disclosed |
| US-4267383-A | USING A COMPLEX CATALYST FROM A TRIARYL PHOSPHINE AND A RHODIUM CARBONYL HYDRIDE OR CHLORIDE | CELANESE CORPORATION (US) | 1981-05-12 | — | — | US | disclosed |
| US-4110404-A | Hydrocarbonylation | CELANESE CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197390-A1 | Neutral-cationic lipid for systemic delivery of factor VIII gene | F13B, F13A1, F8 | CTSL 1521/4885CTSB 1212/4885CTSK 1292/4885 |
| US-20050191344-A1 | Liposome composition for delivery of therapeutic agents | PHOSPHO1, LIPA, SGMS1 | CTSL 1685/4885CTSB 1612/4885CTSK 2808/4885 |
| US-20030031704-A1 | Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic | DLST, LIPA, DNAJC10 | CTSL 2225/4885CTSB 2405/4885CTSK 3739/4885 |
| US-20040166150-A1 | Neutral-cationic lipid for systemic delivery of Factor VIII gene | F8, F13B, F13A1 | CTSL 2805/4885CTSB 2456/4885CTSK 2095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.